Federal Register / Vol. 86, No. 160 / Monday, August 23, 2021 / Notices 47123 

Contact Person: Nijaguna Prasad, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Institute on Aging, National 

Institutes of Health, 7201 Wisconsin Avenue, 

Gateway Building, Suite 2W200, Bethesda, 

MD 20892, 301–496–9667, nijaguna.prasad@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: August 18, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–18051 Filed 8–20–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director; Notice of Charter 

Renewal 

In accordance with Title 42 of the 

U.S. Code of Federal Regulations, 

Section 217a, notice is hereby given that 

the Charter for the Advisory Committee 

to the Deputy Director for Intramural 

Research, National Institutes of Health 

was renewed for an additional two-year 

period on August 15, 2021. 

It is determined that the Advisory 

Committee to the Deputy Director for 

Intramural Research, National Institutes 

of Health is in the public interest in 

connection with the performance of 

duties imposed on the National 

Institutes of Health by law, and that 

these duties can best be performed 

through the advice and counsel of this 

group. 

Inquiries may be directed to Claire 

Harris, Director, Office of Federal 

Advisory Committee Policy, Office of 

the Director, National Institutes of 

Health, 6701 Democracy Boulevard, 

Suite 1000, Bethesda, Maryland 20892 

(Mail Stop Code 4875), Telephone (301) 

496–2123, or harriscl@mail.nih.gov. 

Dated: August 17, 2021. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–17989 Filed 8–20–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Digestive Diseases 

Research Core Centers (P30). 

Date: November 18–19, 2021. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: NIDDK, National Institutes of 

Health, 6707 Democracy Boulevard, Room 

7011, Bethesda, MD 20892 (Video Meeting). 

Contact Person: Jian Yang, Ph.D., Scientific 

Review Officer, Review Branch, Division of 

Extramural Activities, NIDDK, NIH Room 

7011, 6707 Democracy Boulevard, Bethesda, 

MD 20892–5452, (301) 594–7799, yangj@

extra.niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: August 18, 2021. 

Miguelina Perez, 

Program Analyst. Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–18039 Filed 8–20–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Alcohol Abuse 

and Alcoholism; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Special 

Emphasis Panel; Integrative Neuroscience 

Initiative on Alcoholism (INIA) Consortia 

(RFA AA 21–011,012,013) Review Panel A. 

Date: October 14, 2021. 

Time: 9:30 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Institute on Alcohol Abuse and 

Alcoholism, 6700B Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Beata Buzas, Ph.D., 

Scientific Review Officer, Extramural Project 

Review Branch, Office of Extramural 

Activities, National Institute on Alcohol 

Abuse and Alcoholism, 6700B Rockledge 

Drive, Room 2116, MSC 6902, Bethesda, MD 

20817, (301) 443–0800, bbuzas@mail.nih.gov. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Initial 

Review Group; Biomedical Research Study 

Section. 

Date: October 19, 2021. 

Time: 10:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Institute on Alcohol Abuse and 

Alcoholism, 6700B Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Philippe Marmillot, Ph.D., 

Scientific Review Officer, Extramural Project 

Review Branch, National Institutes of Health, 

National Institute on Alcohol Abuse and 

Alcoholism, 6700B Rockledge Drive, Room 

2118, MSC 6902, Bethesda, MD 20892, 301– 

443–2861, marmillotp@mail.nih.gov. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Initial 

Review Group; Epidemiology, Prevention 

and Behavior Research Study Section. 

Date: October 25–26, 2021. 

Time: 9:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Institute on Alcohol Abuse and 

Alcoholism, 6700B Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Anna Ghambaryan, M.D., 

Ph.D., Scientific Review Officer, Extramural 

Project Review Branch, Office of Extramural 

Activities, National Institute on Alcohol 

Abuse and Alcoholism, 6700B Rockledge 

Drive, Room 2120, MSC 6902, Bethesda, MD 

20892, 301–443–4032, anna.ghambaryan@

nih.gov. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Special 


jbell on DSKJLSW7X2PROD with NOTICES
47124 Federal Register / Vol. 86, No. 160 / Monday, August 23, 2021 / Notices 

Emphasis Panel; NIAAA Individual 

Fellowship (F30, F31, F32) Review Panel. 

Date: October 27, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Institute on Alcohol Abuse and 

Alcoholism, 6700B Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Luis Espinoza, Ph.D., 

Scientific Review Officer, Extramural Project 

Review Branch, Office of Extramural 

Activities, National Institute on Alcohol 

Abuse and Alcoholism, 6700B Rockledge 

Drive, Room 2109, Bethesda, MD 20892, 

(301) 443–8599, espinozala@mail.nih.gov. 

Name of Committee: National Institute on 

Alcohol Abuse and Alcoholism Initial 

Review Group; Neuroscience and Behavior 

Study Section. 

Date: October 28, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

National Institute on Alcohol Abuse and 

Alcoholism, 6700B Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Beata Buzas, Ph.D., 

Scientific Review Officer, Extramural Project 

Review Branch, Office of Extramural 

Activities, National Institute on Alcohol 

Abuse and Alcoholism, 6700B Rockledge 

Drive, Room 2116, MSC 6902, Bethesda, MD 

20892, 301–443–0800, bbuzas@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.271, Alcohol Research 

Career Development Awards for Scientists 

and Clinicians; 93.272, Alcohol National 

Research Service Awards for Research 

Training; 93.273, Alcohol Research Programs; 

93.891, Alcohol Research Center Grants; 

93.701, ARRA Related Biomedical Research 

and Research Support Awards., National 

Institutes of Health, HHS) 

Dated: August 17, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–17930 Filed 8–20–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; The Autoantigens 

and Neoantigens Function in the Etiology 

and Pathophysiology of T1D. 

Date: October 22, 2021. 

Time: 1:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Diabetes and 

Digestive and Kidney Diseases, NIH, 6707 

Democracy Boulevard, Room 7007, Bethesda, 

MD 20892 (Video Meeting). 

Contact Person: Lan Tian, Ph.D., Review 

Branch, Division of Extramural Activities, 

NIDDK, NIH, 6707 Democracy Boulevard, 

Room 7007, Bethesda, MD 20892, Phone: 

301–496–7050, tianl@niddk.nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; Development of 

Swallowable Smart Pills/Devices (phased 

R21/R33). 

Date: November 2, 2021. 

Time: 11:00 a.m. to 1:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Diabetes and 

Digestive and Kidney Diseases, NIH, 6707 

Democracy Boulevard, Room 7007, Bethesda, 

MD 20892 (Video Meeting). 

Contact Person: Lan Tian, Ph.D., Review 

Branch, Division of Extramural Activities, 

NIDDK, NIH, 6707 Democracy Boulevard, 

Room 7007, Bethesda, MD 20892, Phone: 

301–496–7050, tianl@niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: August 18, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–18041 Filed 8–20–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director; National 

Institutes of Health Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the HEAL (Helping to 

End Addiction Long-Term) MultiDisciplinary Working Group, September 

01, 2021, 10:30 a.m. to September 02, 

2021, 03:45 p.m., National Institutes of 

Health, Building 1, Wilson Hall, 1 

Center Drive, Bethesda, MD 20892 

which was published in the Federal 

Register on August 10, 2021, FR Doc 

2021–17012, 86 FR 43669. 

This notice is being amended to 

update the meeting times for the HEAL 

Multi-Disciplinary Working Group 

Meeting on September 1–2, 2021. Open: 

September 01, 2021, 11:00 a.m. to 12:00 

p.m.; Closed: September 01, 2021, 12:00 

p.m. to 4:30 p.m.; Closed: September 02, 

2021, 11:00 a.m. to 4:30 p.m. The 

meeting is partially Closed to the public. 

The open portion of the meeting will be 

live webcast at: https://

videocast.nih.gov/. 

Dated: August 18, 2021. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–18048 Filed 8–20–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: NIGMS Initial Review 

Group Training and Workforce Development 

Study Section—D NIGMS Review of SuRE 

Applications. 

Date: October 7–8, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892 (Video Meeting). 

Contact Person: Tracy Koretsky, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review, National Institute of General Medical 

Sciences, National Institutes of Health, 45 

Center Drive, MSC 6200, Room 3AN.12F, 

Bethesda, MD 20892, 301 594 2886, 

tracy.koretsky@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 


jbell on DSKJLSW7X2PROD with NOTICES